Šveits - saksa - myHealthbox

bayer ag - spirotetramat - suspensionskonzentrat (sc) - 9.26 %100 g/l; - 100 g/l spirotetramat ( ) - insektizid ;

Saksamaa - saksa - BVL (Bundesamt für Verbraucherschutz und Lebensmittelsicherheit)

bayer ag - emulsionskonzentrat - 160 g/l prothioconazol; 200 g/l spiroxamine; 40 g/l proquinazid - top

Saksamaa - saksa - BVL (Bundesamt für Verbraucherschutz und Lebensmittelsicherheit)

bayer ag - emulsionskonzentrat - 81 % rapsölmethylester; 50 g/l iodosulfuron-methyl-natrium; 7,5 g/l mesosulfuron-methyl; 250 g/l mefenpyr-diethyl (safener) - herbizid

Euroopa Liit - saksa - EMA (European Medicines Agency)

lipomed gmbh - thalidomid - multiples myelom - immunsuppressiva - thalidomide lipomed in combination with melphalan and prednisone is indicated as first line treatment of patients with untreated multiple myeloma, aged ≥ 65 years or ineligible for high dose chemotherapy. thalidomide lipomed is prescribed and dispensed in accordance with the thalidomide lipomed pregnancy prevention programme (see section 4.

Euroopa Liit - saksa - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - thalidomid - multiples myelom - immunsuppressiva - thalidomide bms in combination with melphalan and prednisone as first line treatment of patients with untreated multiple myeloma, aged >/= 65 years or ineligible for high dose chemotherapy. thalidomide bms is prescribed and dispensed according to the thalidomide celgene pregnancy prevention programme (see section 4.

Šveits - saksa - myHealthbox

bayer ag - difenoconazol; solvent naphtha (petroleum), heavy arom.; kerosine - unspecified; (z)-9-octadecen-1-ol ethoxylated - emulsionskonzentrat (ec) - 23.5 %250 g/l; ; ; - 250 g/l difenoconazol - fungizid ;

Šveits - saksa - OFAG-BLW (Bundesamt für Landwirtschaft)

bayer (schweiz) ag - difenoconazol; solvent naphtha (petroleum), heavy arom.; kerosine - unspecified; (z)-9-octadecen-1-ol ethoxylated - ecemulsionskonzentrat - 23.5 %250 g/l; ; ; - fungizid ;

Euroopa Liit - saksa - EMA (European Medicines Agency)

mylan pharmaceuticals limited - teriflunomide - multiple sklerose, schubförmig-remittierender - immunsuppressiva - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

Euroopa Liit - saksa - EMA (European Medicines Agency)

accord healthcare s.l.u. - teriflunomide - multiple sklerose, schubförmig-remittierender - immunsuppressiva, selektive immunsuppressiva - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

Austria - saksa - AGES (Agentur für Gesundheit und Ernährungssicherheit)

biotest pharma gmbh - immunglobulin - immunglobuline, normal